An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma.

作者: Neda Mosakhani , Mohamed Guled , Gayle Leen , Silvia Calabuig-Fariñas , Tarja Niini

DOI: 10.1186/1756-9966-31-24

关键词:

摘要: Xenografts have been shown to provide a suitable source of tumor tissue for molecular analysis in the absence primary material. We utilized ES xenograft series integrated microarray analyses identify novel biomarkers. Microarray technology (array comparative genomic hybridization (aCGH) and micro RNA arrays) was used screen copy number changes differentially expressed miRNAs 34 14 passages, respectively. Incubated cells xenografting (Passage 0) were considered represent tumor. Four important (miR-31, miR-31*, miR-145, miR-106) selected further validation by real time polymerase chain reaction (RT-PCR). Integrated aCGH miRNA data performed on passages bioinformatic methods. The most frequent losses gains DNA detected at 9p21.3, 16q 8, 15, 17q21.32-qter, 1q21.1-qter, presence these alterations consistent all passages. profiles each resembled their corresponding tumors (passage 0). MiR-21, miR-31, miR-106b, miR-150*, miR-371-5p, miR-557 miR-598 showed recurrently altered expression. These miRNAS predicted regulate many ES-associated genes, such as genes IGF1 pathway, EWSR1, FLI1 fusion gene (EWS-FLI1). Twenty pinpointed regions carrying numbers. In present study, xenografts successfully applied analyses. Our findings expression that associated pathway FLI1, EWS-FLI1 genes.

参考文章(51)
Sophie Brisset, Gudrun Schleiermacher, Martine Peter, Aline Mairal, Odile Oberlin, Olivier Delattre, Alain Aurias, CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases. Cancer Genetics and Cytogenetics. ,vol. 130, pp. 57- 61 ,(2001) , 10.1016/S0165-4608(01)00454-X
Irene L. Andrulis, Michael Pollak, Cara Ohashi, Robert S. Bell, Ato Sekyi-Otu, Insulin-like Growth Factor 1 (IGF-1) Receptors, IGF-1, and IGF-2 Are Expressed in Primary Human Sarcomas Cancer Research. ,vol. 55, pp. 129- 134 ,(1995)
Stephan A Hahn, Albert B Seymour, ATM Shamsul Hoque, Mieke Schutte, Luis T da Costa, Mark S Redston, Carlos Caldas, Craig L Weinstein, Aryeh Fischer, Charles J Yeo, Ralph H Hruban, Scott E Kern, None, Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Research. ,vol. 55, pp. 4670- 4675 ,(1995)
Oscar W. Cummings, Sakari Knuutila, Wa'el El-Rifai, Henry F. Frierson, Steven M. Powell, Jeffrey C. Harper, Eija Riitta Hyytinen, Consistent Genetic Alterations in Xenografts of Proximal Stomach and Gastro-Esophageal Junction Adenocarcinomas Cancer Research. ,vol. 58, pp. 34- 37 ,(1998)
L. Zhang, J. Huang, N. Yang, J. Greshock, M. S. Megraw, A. Giannakakis, S. Liang, T. L. Naylor, A. Barchetti, M. R. Ward, G. Yao, A. Medina, A. O'Brien-Jenkins, D. Katsaros, A. Hatzigeorgiou, P. A. Gimotty, B. L. Weber, G. Coukos, microRNAs exhibit high frequency genomic alterations in human cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 9136- 9141 ,(2006) , 10.1073/PNAS.0508889103
Enrique de Alava, Cristina R. Antonescu, Angel Panizo, Denis Leung, Paul A. Meyers, Andrew G. Huvos, F. Javier Pardo-Mind�n, John H. Healey, Marc Ladanyi, Prognostic impact of P53 status in Ewing sarcoma. Cancer. ,vol. 89, pp. 783- 792 ,(2000) , 10.1002/1097-0142(20000815)89:4<783::AID-CNCR10>3.0.CO;2-Q
Julia Winter, Stephanie Jung, Sarina Keller, Richard I. Gregory, Sven Diederichs, Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology. ,vol. 11, pp. 228- 234 ,(2009) , 10.1038/NCB0309-228
Claudine L Bartels, Gregory J Tsongalis, MicroRNAs: Novel Biomarkers for Human Cancer Clinical Chemistry. ,vol. 55, pp. 623- 631 ,(2009) , 10.1373/CLINCHEM.2008.112805
Baljit Singh, Dona Charkowicz, Desmond Mascarenhas, Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. Journal of Biological Chemistry. ,vol. 279, pp. 477- 487 ,(2004) , 10.1074/JBC.M307322200
G. H. S. Richter, S. Plehm, A. Fasan, S. Rossler, R. Unland, I. M. Bennani-Baiti, M. Hotfilder, D. Lowel, I. von Luettichau, I. Mossbrugger, L. Quintanilla-Martinez, H. Kovar, M. S. Staege, C. Muller-Tidow, S. Burdach, EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 5324- 5329 ,(2009) , 10.1073/PNAS.0810759106